Hepatocyte transplantation for treating chronic hepatic dysfunction

Journal of Organ Dysfunction

Volumn 3, Issue 3, 2007, Pages 131-136

  Zamora Valdés, Daniel ^a   Guibert, Edgardo E ^b   Rodríguez, Joaquín V ^b   Uribe, Misael ^a   Méndez Sánchez, Nahum ^a  

^a LIVER RESEARCH UNIT   (Mexico)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

Author keywords

Chronic liver disease; Hepatic encephalopathy; Hepatocyte transplantation; Liver regeneration

Indexed keywords

CARBON TETRACHLORIDE; CYCLOPHOSPHAMIDE; GLYCERYL TRINITRATE; NITROPRUSSIDE SODIUM; PHENTOLAMINE; RADIOISOTOPE; SCATTER FACTOR;

CELL LINE; CHRONIC LIVER DISEASE; EXPERIMENTATION; HEPATOCYTE TRANSPLANTATION; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER REGENERATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 34848916654     PISSN: 17471060     EISSN: 17471079     Source Type: Journal    
DOI: 10.1080/17471060601137456     Document Type: Review

References (47)

1. Aeschylus. The tragedies of Aeschylus: literally translated. London, UK: G. Bell & Sons; 1876.
2. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology 2006;43:S45-53.
3. Sandgren EP, Palmiter RD, Heckel JL, Daugherty CC, Brinster RL, Degen JL. Complete hepatic regeneration after somatic deletion of an albumin-plasminogen activator transgene. Cell 1991;66:245-56.
4. Kvittingen EA, Rootwelt H, Berger R, Brandtzaeg P. Self-induced correction of the genetic defect in tyrosinemia type I. J Clin Invest 1994;94:1657-61.
5. Mendez-Sanchez N, Pichardo-Bahena R, Almeda-Valdes P. Cirrosis hepatica. In: Méndez-Sánchez N, Uribe M, editors. Gastroenterologia. Mexico City, Mexico: McGraw-Hill; 2005.
6. Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 2001;120: 749-62.
7. Di Bisceglie AM. Natural history of hepatitis C: its impact on clinical management. Hepatology 2000;31:1014-8.
8. Secretaria de Salud. Base de datos de información sobre mortalidad. 2005. Available at: http://www.salud.gob.mx/apps/htdocs/ estadisticas/publicaciones/Mortalidad2000.zip
9. Mendez-Sanchez N, Villa AR, Chavez-Tapia NC, Ponciano-Rodriguez G, Almeda-Valdes P, Gonzalez D, et al. Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data. Ann Hepatol 2005;4:52-5.
10. Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman RK. Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD). Liver Transpl Surg 1997;3:93-104.
11. Best JH, Veenstra DL, Geppert J. Trends in expenditures for Medicare liver transplant recipients. Liver Transpl 2001;7: 858-62.
12. Trotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. N Engl J Med 2002;346:1074-82.
13. Surman OS. The ethics of partial-liver donation. N Engl J Med 2002;346:1038.
14. Otte JB, de Ville de Goyet J, Reding R, Van Obbergh L, Veyckemans F, Carlier MA, et al. Pediatric liver transplantation: from the full-size liver graft to reduced, split, and living related liver transplantation. Pediatr Surg Int 1998;13: 308-18.
15. United Network for Organ Sharing. 2006. Available at: www.unos.org
16. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000;31:864-71.
17. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33: 464-70.
18. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124: 91-6.
19. Brown J, Sorrell JH, McClaren J, Creswell JW. Waiting for a liver transplant. Qual Health Res 2006;16:119-36.
20. Bruzzone P, Strom SC. Historical aspects of hepatocyte transplantation. Transplant Proc 2006;38:1179-80.
21. Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for metabolic disorders, experience at King's College hospital and review of literature. Acta Gastroenterol Belg 2005;68:457-60.
22. Strom SC, Bruzzone P, Cai H, Ellis E, Lehmann T, Mitamura K, et al. Hepatocyte transplantation: clinical experience and potential for future use. Cell Transplant 2006;15(Suppl 1):S105-10.
23. Baccarani U, Adani GL, Sainz M, Donini A, Risaliti A, Bresadola F. Human hepatocyte transplantation for acute liver failure: state of the art and analysis of cell sources. Transplant Proc 2005;37:2702-4.
24. Vogels BA, Maas MA, Bosma A, Chamuleau RA. Significant improvement of survival by intrasplenic hepatocyte transplantation in totally hepatectomized rats. Cell Transplant 1996;5: 369-78.
25. Fox IJ, Chowdhury JR, Kaufman SS, Goertzen TC, Chowdhury NR, Warkentin PI, et al. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422-6.
26. Strom SC, Chowdhury JR, Fox IJ. Hepatocyte transplantation for the treatment of human disease. Semin Liver Dis 1999;19:39-48.
27. Mitry RR, Hughes RD, Aw MM, Terry C, Mieli-Vergani G, Girlanda R, et al. Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant 2003;12:69-74.
28. Haghighi KS, Woon WW, Akhter J, Marr PJ, Bolton E, Riordan S, et al. A new source of hepatocytes for transplantation. Transplant Proc 2004;36:2466-8.
29. Schumacher IK, Okamoto T, Kim BH, Chowdhury NR, Chowdhury JR, Fox IJ. Transplantation of conditionally immortalized hepatocytes to treat hepatic encephalopathy. Hepatology 1996;24:337-43.
30. Cai J, Ito M, Nagata H, Westerman KA, Lafleur D, Chowdhury JR, et al. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes. Hepatology 2002;36:386-94.
31. Yamaguchi K, Itoh K, Masuda T, Umemura A, Baum C, Itoh Y, et al. In vivo selection of transduced hematopoietic stem cells and little evidence of their conversion into hepatocytes in vivo. J Hepatol 2006;45:681-7.
32. Oh SH, Miyazaki M, Kouchi H, Inoue Y, Sakaguchi M, Tsuji T, et al. Hepatocyte growth factor induces differentiation of adult rat bone marrow cells into a hepatocyte lineage in vitro. Biochem Biophys Res Commun 2000;279:500-4.
33. Ishikawa T, Terai S, Urata Y, Marumoto Y, Aoyama K, Sakaida I, et al. Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes. Cell Tissue Res 2006;323:221-31.
34. Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results. Transplantation 2006;82:441-9.
35. Gupta S, Vemuru RP, Lee CD, Yerneni PR, Aragona E, Burk RD. Hepatocytes exhibit superior transgene expression after transplantation into liver and spleen compared with peritoneal cavity or dorsal fat pad: implications for hepatic gene therapy. Hum Gene Ther 1994;5:959-67.
36. Malhi H, Annamaneni P, Slehria S, Joseph B, Bhargava KK, Palestro CJ, et al. Cyclophosphamide disrupts hepatic sinusoidal endothelium and improves transplanted cell engraftment in rat liver. Hepatology 2002;36:112-21.
37. Slehria S, Rajvanshi P, Ito Y, Sokhi RP, Bhargava KK, Palestro CJ, et al. Hepatic sinusoidal vasodilators improve transplanted cell engraftment and ameliorate microcirculatory perturbations in the liver. Hepatology 2002;35:1320-8.
38. Sigot V, Mediavilla MG, Furno G, Rodriguez JV, Guibert EE. A simple and effective method to improve intrasplenic rat hepatocyte transplantation. Cell Transplant 2004;13:775-81.
39. Gagandeep S, Rajvanshi P, Sokhi RP, Slehria S, Palestro CJ, Bhargava KK, et al. Transplanted hepatocytes engraft, survive, and proliferate in the liver of rats with carbon tetrachloride-induced cirrhosis. J Pathol 2000;191:78-85.
40. Ribeiro J, Nordlinger B, Ballet F, Cynober L, Coudray-Lucas C, Baudrimont M, et al. Intrasplenic hepatocellular transplantation corrects hepatic encephalopathy in portacaval-shunted rats. Hepatology 1992;15:12-8.
41. Mariani P, Coudray-Lucas C, Baudrimont M, Ribeiro J, Legendre C, Delelo R, et al. Glutamine metabolism and neuropathological disorders in experimental hepatic encephalopathy: effect of transplanted hepatocytes. Surgery 1996; 120:93-9.
42. Kobayashi N, Ito M, Nakamura J, Cai J, Gao C, Hammel JM, et al. Hepatocyte transplantation in rats with decompensated cirrhosis. Hepatology 2000;31:851-7.
43. Kato K, Onodera K, Sawa M, Imai M, Kawahara T, Kasai S, et al. Effect of hepatocyte growth factor on the proliferation of intrasplenically transplanted hepatocytes in rats. Biochem Biophys Res Commun 1996;222:101-6.
44. Xue F, Takahara T, Yata Y, Kuwabara Y, Shinno E, Nonome K, et al. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 2003;52:694-700.
45. Kim WH, Matsumoto K, Bessho K, Nakamura T. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol 2005;166:1017-28.
46. Mito M, Kusano M, Kawaura Y. Hepatocyte transplantation in man. Transplant Proc 1992;24:3052-3.
47. Strom SC, Fisher RA, Thompson MT, Sanyal AJ, Cole PE, Ham JM, et al. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure. Transplantation 1997;63:559-69.